Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery

International Journal of Biological Macromolecules

Volumn 61, Issue , 2013, Pages 189-195

  Kumar, Manoj ^a   Pandey, Ravi Shankar ^a   Patra, Kartik Chandra ^a   Jain, Sunil Kumar ^a   Soni, Muarai Lal ^a   Dangi, Jawahar Singh ^a   Madan, Jitender ^b  

^a GURU GHASIDAS UNIVERSITY   (India)

^b Chandigarh College of Pharmacy   (India)

Author keywords

Antinociceptive; Brain delivery; Enkephalin; Trimethyl chitosan

Indexed keywords

ACETIC ACID; CHITOSAN DERIVATIVE; LEUCINE ENKEPHALIN; NANOPARTICLE; TRIMETHYL CHITOSAN NANOPARTICLE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG DIFFUSION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG TRANSPORT; EX VIVO STUDY; FEMALE; FLUORESCENCE MICROSCOPY; GELATION; HOT PLATE TEST; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MUCOADHESION; NANOENCAPSULATION; NONHUMAN; NOSE MUCOSA; PARTICLE SIZE; PHYSICAL PARAMETERS; POLYDISPERSITY INDEX; PROTON NUCLEAR MAGNETIC RESONANCE; SWINE; WRITHING TEST; ZETA POTENTIAL;

MUS; SUS;

ANTINOCICEPTIVE; BRAIN DELIVERY; ENKEPHALIN; TRIMETHYL CHITOSAN;

ANIMALS; BRAIN; CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENKEPHALIN, LEUCINE; FEMALE; MALE; MICE; NANOPARTICLES; NASAL MUCOSA; NEUROPEPTIDES; NOSE; PERMEABILITY; SWINE;

EID: 84881003810     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2013.06.041     Document Type: Article

References (42)

1. Jankovic B.D., Maric D. Annals of the New York Academy of Sciences 1988, 540:691-693.
2. Frederickson R.C., Geary L.E. Progress in Neurobiology 1982, 19:19-69.
3. Vyas T.K., Shahiwala A., Marathe S., Misra A. Current Drug Delivery 2005, 2:165-175.
4. Illum L. European Journal of Pharmaceutical Sciences 2000, 11:1-18.
5. Illum L. Journal of Pharmacy and Pharmacology 2004, 56:3-17.
6. Thorne R.G., Frey W.H. Clinical Pharmacokinetics 2001, 40:907-946.
7. O'Hagan D.T., Critchley H., Farraj N.F., Fisher A.N., Johansen B.R., Davis S.S., Illum L. Pharmaceutical Research 1990, 7:772-776.
8. Steyn D., du Plessis L., Kotzé A. Journal of Pharmacy & Pharmaceutical Sciences 2010, 13:263-273.
9. Chun I.K., Chien Y.W. Journal of Pharmaceutical Sciences 1993, 82:373-378.
10. Schwartz J.C., Malfroy B., De La Baume S. Life Science 1981, 29:1715-1740.
11. Amidi M., Romeijn S.G., Borchard G., Junginger H.E., Hennink W.E., Jiskoot W. Journal of Controlled Release 2006, 111:107-116.
12. Bickel U., Yoshikawa T., Pardridge W.M. Advanced Drug Delivery Reviews 2001, 46:247-279.
13. Lu W., Zhang Y., Tan Y.Z., Hu K.L., Jiang X.G., Fu S.K. Journal of Controlled Release 2005, 107:428-448.
14. Wang Z.H., Wang Z.Y., Sun C.S., Wang C.Y., Jiang T.Y., Wang S.L. Biomaterials 2010, 31:908-915.
15. Wang S., Jiang T., Ma M., Hu Y., Zhang J. International Journal of Pharmaceutics 2010, 386:249-255.
16. Sieval A.B., Thanou M., Kotz'e A.F., Verhoef J.C., Brussee J., Junginger H.E. Carbohydrate Polymers 1998, 36:157-165.
17. Seju U., Kumar A., Sawant K.K. Acta Biomaterialia 2011, 7:4169-4176.
18. Liu S., Shibata A., Ueno S., Xu F., Baba Y., Jiang D., Li Y. Colloids and Surfaces B: Biointerfaces 2006, 48:148-158.
19. Brady L.S., Holtzman S.G. Journal of Pharmacology and Experimental Therapeutics 1982, 222:190-197.
20. Gwak H.S., Cho Y.M., Chun I.K. Journal of Pharmacy and Pharmacology 2003, 55:1207-1212.
21. Tiwari S.B., Amiji M.M. Current Drug Delivery 2006, 3:219-232.
22. Illum L. Journal of Controlled Release 2003, 87:187-198.
23. Hamman J.H., Stander M., Kotz'e A.F. International Journal of Pharmaceutics 2002, 232:235-242.
24. Hagenaars N., Verheul R.J., Mooren I., De Jong P.H.J.L.F., Mastrobattista E., Glansbeek H.L., Heldens J.G.M., Bosch Van den H., Hennink W.E., Jiskoot W. Journal of Controlled Release 2009, 140:126-133.
25. Vander Lubben I.M., Verhoef J.C., Borchard G., Junginger H.E. European Journal of Pharmaceutical Sciences 2001, 14:201-207.
26. Shu X.Z., Zhu K.J. International Journal of Pharmaceutics 2002, 21:217-225.
27. Agarwal V., Mishra B. Indian Journal of Experimental Biology 1999, 37:6-16.
28. Rawat A., Majumder Q.H., Ahsan F. Journal of Controlled Release 2008, 128:224-232.
29. Hamdy S., Haddadi A., Hung R.W., Lavasanifar A. Advanced Drug Delivery Reviews 2011, 63:943-955.
30. Xu Y., Du Y., Huang R., Gao L. Biomaterials 2003, 24:5015-5022.
31. Kreuter J. Infection 1991, 19:224-228.
32. Takeuchi H., Yamamoto H., Niwa T., Hino T., Kawashima Y. Pharmaceutical Research 1996, 13:896-901.
33. Takeuchi H., Yamamoto H., Kawashima Y. Advanced Drug Delivery Reviews 2001, 23:39-54.
34. Boonyo W., Junginger H.E., Waaranuch N., Plonk A., Pitaksuteepong T. Journal of Controlled Release 2007, 28:168-175.
35. Soane R.J., Frier M., Perkins A.C., Jones N.S., Davis S.S., Illum L. International Journal of Pharmaceutics 1999, 178:55-65.
36. Osth K., Strindelius L., Larhed A., Ahlander A., Roomans G.M., Sjoholm I., Bjork E. Journal of Drug Targeting 2003, 11:75-82.
37. Bernkop-Schnürch A., Obermair K., Greimel A., Palmberger T.F. Amino Acids 2006, 30:417-423.
38. Beirith A., Santos A.R., Rodrigues A.L., Creczynski-Pasa T.B., Calixto J.B. European Journal of Pharmacology 1998, 345:233-245.
39. Yaksh T.L., Rudy T.A. Pain 1978, 4:299-359.
40. Collier H.O., Dinneen L.C., Johnson C.A., Schneider C. British Journal of Pharmacology and Chemotherapy 1968, 32:295-310.
41. Inoue H., Kurosu S., Takeuchi T., Mori T., Shibata S. Journal of Pharmacy and Pharmacology 1990, 42:199-200.
42. Thorne R.G., Pronk G.J., Padmanabhan V., Frey W.H. Neuroscience 2004, 127:481-496.